News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ATEL Ventures Portfolio Company, ARYx Therapeutics, Inc. Completes Initial Public Offering



12/6/2007 12:13:45 PM

SAN FRANCISCO--(BUSINESS WIRE)--ATEL Ventures, a leading provider of secured financing to emerging growth companies, is pleased to announce that its portfolio company, ARYx Therapeutics, Inc. (NASDAQ:ARYX) completed its initial public offering. ARYx Therapeutics, Inc., offering included 5,000,000 shares of its common stock at $10.00 per share in the offering.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES